Eleftha 150mg Injection (Trustuzumab)
Eleftha 150mg Injection (Trustuzumab)

Eleftha 150mg Injection (Trustuzumab)

prescriptionImage Prescription Required

Manufactured By

Intas

Pack Of

1

Salt Composition

Trustuzumab

Storage

Keep in cold place

Safe and Secure


Your health and safety are our top priority. All our medicines are sourced from trusted suppliers, thoroughly tested, and approved for use. We follow strict quality control standards to ensure every product is safe, effective, and reliable. Shop with confidence knowing your wellness is in good hands.

Fast Delivery

Fast Delivery

Easy Returns

Easy Returns

Secure Payments

Secure Payments

Up to 60% Discounts

Up to 60% Discounts

ALL SUBSTITUTES

Priunta 150mg Injection

Priunta 150mg Injection

Herti 440mg Injection

Herti 440mg Injection

Neumab 150mg Injection

Neumab 150mg Injection

Hervycta 440mg Injection

Hervycta 440mg Injection

Trazumab 440mg Injection

Trazumab 440mg Injection

Hersima 440mg Injection

Hersima 440mg Injection

Hersima 150mg Injection

Hersima 150mg Injection

Herti 150mg Injection

Herti 150mg Injection

Trumab 150mg Injection

Trumab 150mg Injection

Kintsugi 150mg Injection

Kintsugi 150mg Injection

Ontramab 440mg Injection

Ontramab 440mg Injection

Hervycta 150mg Injection

Hervycta 150mg Injection

Priunta 440mg Injection

Priunta 440mg Injection

Neuzumab 440mg Injection

Neuzumab 440mg Injection

Vivitra 440mg Injection

Vivitra 440mg Injection

Overview

Eleftha 150mg Injection is targeted monoclonal antibody therapy due to its main composition Trustuzumab. It is prescribed to treat HER2-positive breast cancer and stomach cancer.

It works by blocking the action of HER2 receptors to control the progression of cancer. It should be administered by a doctor or experienced nurse. Don't self-administer the injection.

Quick Product Facts

FieldPublication wording
Brandeleftha
Generic / Active IngredientTrustuzumab
Strength150
Dosage FormInjection
Manufacturer / MarketerIntas
Pack Size1
Prescription RequiredYes
Therapeutic CategoriesCancer Medicines
UsesStomach Cancer

Uses and Indications

Breast cancer, Stomach Cancer

Side Effects of Eleftha 150mg Injection

The human body reacts differently to Eleftha 150mg Injection(Trustuzumab 150mg). Response or undesired symptoms vary from individual to individual. Usually, they disappear with time as the body adjusts to the medicine. These side effects don't need special medical attention. Some of the common side effects include:
● Anemia (low number of red blood cells)
● Chills
● Common cold
● Cough
● Decreased blood cells (red cells, white cells, and platelets)
● Diarrhea
● Fatigue
● Fever
● Headache
● Heart failure
● Infection
● Insomnia (difficulty in sleeping)
● Mucosal inflammation
● Nausea
● Rash
● Stomatitis (Inflammation of the mouth)
● Taste change
● Upper respiratory tract infection
● Weight loss
However, if the symptoms don't disappear with time or you have severe side effects, then consult your doctor immediately.

Common or Clinically Frequent Side Effects

  • n

Eleftha 150mg Injection Dosage and How To Take It

Eleftha 150mg(Trustuzumab 150mg Injection) is available in injection form and is advised to be taken as per the doctor's prescription. It can only be given intravenously or as a drip by a doctor or nurse under strict medical supervision.

Taking this injection in the wrong way may give you severe side effects. In case of overdose, contact your healthcare provider or doctor and they will provide you with medical attention. Missing or overdosing will impact the overall health of the patients and may also have side effects.

Safety Advice for Eleftha 150mg Injection

  • ● Alcohol: Avoid the consumption of alcohol while taking Eleftha 150mg Injection(Trustuzumab), as alcohol can reduce the effectiveness of the medicine and worsen the symptoms.
  • ● Pregnancy: Eleftha 150mg Injection is not recommended during pregnancy as it is unsafe for the developing fetus.
  • ● Breastfeeding: Breastfeeding women should discuss the potential risks and benefits of the Eleftha 150mg Injection(Trustuzumab 150mg) with their healthcare provider before starting treatment.
  • ● Driving: Patients should avoid driving or operating machinery while taking Eleftha 150mg Injection if they experience side effects such as fatigue, dizziness, or blurred vision.
  • ● Kidney: Eleftha 150mg Injection(Trustuzumab Injection) is safe for use in kidney disease if prescribed by the doctor. No dosage adjustment is necessary for this Tablet.
  • ● Liver: Avoid Eleftha 150mg Injection consumption if you have any liver-related issues because this medicine causes liver toxicity, which can make your condition worse.

FAQs About Eleftha 150mg Injection

What is the use of Eleftha 150mg Injection(Trustuzumab)?

downArrowImg

Eleftha 150mg Injection is prescribed to treat certain types of cancer of blood, breast, stomach, lung, ovaries and soft tissues.

What are the adverse impact of Eleftha 150mg Injection?

downArrowImg

Some common side effects patients may experience, such as low blood platelets, less hunger, weight loss, nausea, headache, dehydration etc.

How to take Eleftha 150mg Injection?

downArrowImg

Eleftha 150mg Injection(Trustuzumab) can only be given intravenously or as a drip by a doctor or nurse under strict medical supervision.

How does Eleftha 150mg Injection works?

downArrowImg

Eleftha 150mg Injection works to inhibit the activity of enzyme involved in DNA multiplication to control the progression of cancer.

Is it safe to take Eleftha 150mg Injection(Trustuzumab) in liver related condition?

downArrowImg

No, don't take Eleftha 150mg in case of liver related condition without consulting the doctor.

References

● Barok, M., Joensuu, H., & Isola, J. (2014). Trastuzumab emtansine: mechanisms of action and drug resistance. Breast cancer research, 16(2), 209.
● Perry, C. M., & Wiseman, L. R. (1999). Trastuzumab. BioDrugs, 12(2), 129-135.
● Maximiano, S., Magalhaes, P., Guerreiro, M. P., & Morgado, M. (2016). Trastuzumab in the treatment of breast cancer. BioDrugs, 30(2), 75-86.
● Cortés, J., Kim, S. B., Chung, W. P., Im, S. A., Park, Y. H., Hegg, R., ... & Hurvitz, S. A. (2022). Trastuzumab deruxtecan versus trastuzumab emtansine for breast cancer. New England Journal of Medicine, 386(12), 1143-1154.
● Boekhout, A. H., Beijnen, J. H., & Schellens, J. H. (2011). Trastuzumab. The oncologist, 16(6), 800-810.

Marketer Details

Intas

Rating and Reviews

4.4/5

9 Reviews

Kevin - ⭐ 1/5

Worst Experience Ever

Author Details

logoImg

Written By:

Nonish Sharma

I am a medical content writer with a strong academic background in life sciences, holding an M.Sc. in Biotechnology... Read More


reviewerImg

Reviewed By:

Vaibhav Shakya

Dr. Vaibhav Shakya, MD, is a Medical reviewer and medicine expert at Globans Pharma, with more than 9 years of experienc... Read More

Last Updated: 14 Sept 2026 | 08:12 am (IST)

Want to know More

Check our Editor Policy

Disclaimer

Globanspharma main goal is to ensure that its consumers get correct, authentic, and reliable information that has been examined by medical professionals. This website's content has only been created for informational purposes. However, this is not meant to replace the medical advice and treatment given by a qualified physician. The information presented herein may not cover everything about particular lab tests, medicines, and health conditions, all possible side effects, and warnings. Please discuss all your queries related to any medication and illness with your doctor. We intend to support and maintain the doctor-patient relationship, not to substitute it or take its place.

Chat on WhatsApp